<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1. Pharmacokinetics in Normal Volunteers: Single 8 mg Ondansetron Tablet Dose 
</caption>
<tbody>
<tr>
<td>
<br/>Age-group (years)</td>
<td>Mean Weight (kg)<br/>
</td>
<td>n<br/>
</td>
<td>Peak Plasma Concentration (ng/mL)<br/>
</td>
<td>Time of Peak Plasma Concentration(h)<br/>
</td>
<td>Mean Elimination Half-life (h)<br/>
</td>
<td>Systemic Plasma Clearance L/h/kg<br/>
</td>
<td>Absolute Bioavailability<br/>
</td>
</tr>
<tr>
<td>18 to 40 M            <br/>F</td>
<td>69<br/>
</td>
<td>6<br/>
</td>
<td>26.2<br/>
</td>
<td>2<br/>
</td>
<td>3.1<br/>
</td>
<td>0.403<br/>
</td>
<td>0.483<br/>
</td>
</tr>
<tr>
<td>62.7<br/>
</td>
<td>5<br/>
</td>
<td>42.7<br/>
</td>
<td>1.7<br/>
</td>
<td>3.5<br/>
</td>
<td>0.354<br/>
</td>
<td>0.663<br/>
</td>
</tr>
<tr>
<td>61 to 74 M            <br/>F</td>
<td>77.5<br/>
</td>
<td>6<br/>
</td>
<td>24.1<br/>
</td>
<td>2.1<br/>
</td>
<td>4.1<br/>
</td>
<td>0.384<br/>
</td>
<td>0.585<br/>
</td>
</tr>
<tr>
<td>60.2<br/>
</td>
<td>6<br/>
</td>
<td>52.4<br/>
</td>
<td>1.9<br/>
</td>
<td>4.9<br/>
</td>
<td>0.255<br/>
</td>
<td>0.643<br/>
</td>
</tr>
<tr>
<td>≥ 75 M            <br/>F</td>
<td>78<br/>
</td>
<td>5<br/>
</td>
<td>37<br/>
</td>
<td>2.2<br/>
</td>
<td>4.5<br/>
</td>
<td>0.277<br/>
</td>
<td>0.619<br/>
</td>
</tr>
<tr>
<td>67.6<br/>
</td>
<td>6<br/>
</td>
<td>46.1<br/>
</td>
<td>2.1<br/>
</td>
<td>6.2<br/>
</td>
<td>0.249<br/>
</td>
<td>0.747<br/>
</td>
</tr>
</tbody>
</table>